Search results for "nuclide [thorium]"

showing 10 items of 75 documents

Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications.

2019

Meningiomas account for approximately 30% of all new diagnoses of intracranial masses. The 2016 World Health Organization’s (WHO) classification currently represents the clinical standard for meningioma’s grading and prognostic stratification. However, watchful waiting is frequently the chosen treatment option, although this means the absence of a certain histological diagnosis. Consequently, MRI (or less frequently CT) brain imaging currently represents the unique available tool to define diagnosis, grading, and treatment planning in many cases. Nonetheless, these neuroimaging modalities show some limitations, particularly in the evaluation of skull base lesions. The emerging evidence supp…

Cancer Researchmedicine.medical_specialtypositron emission tomographymedicine.medical_treatmentReviewlcsh:RC254-282meningioma030218 nuclear medicine & medical imagingMeningioma03 medical and health sciences0302 clinical medicineNeuroimagingFunctional neuroimagingmedicineotorhinolaryngologic diseasesMedical diagnosisRadiation treatment planningGrading (tumors)neoplasmsMeningioma; Neuroimaging; Positron emission tomography; Radionuclide therapy; Somatostatin receptorneuroimagingbusiness.industryradionuclide therapylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasesomatostatin receptorOncologymeningioma; somatostatin receptor; neuroimaging; positron emission tomography; radionuclide therapy030220 oncology & carcinogenesisRadionuclide therapyRadiologybusinessWatchful waitingCancers
researchProduct

[Diagnosis of coronary microvascualar dysfunction in diabetic patients with cardiac syndrome X: comparison by current methods].

2013

The study population included 208 patients with chest pain and uninjured coronary arteries that we split into two populations: diabetics (72 patients) and non-diabetics (136 patients). We split patients with chest pain and uninjured coronary arteries that had a myocardial scintigraphy into two populations: patients with positive scintigraphy and negative. We calculated, on angiographic images of each patient, stored on suitable digital supports, Timi Frame Count (TFC), Myocardial Blush Grade (MBG) and Total Myocardial Blush Score (TMBS) using the protocol described by Gibson and Yusuf. On the basis of Yusuf's experience we imagined a new index: the Total Timi Frame Count as the sum of the t…

Cardiac syndrome X chest pain coronary angiography diabetes mellitus microcirculation myocardial scintigraphyChest PainMicrocirculationReproducibility of ResultsCoronary DiseaseCoronary AngiographySeverity of Illness IndexElectrocardiographyPredictive Value of TestsRisk FactorsCoronary CirculationExercise TestHumansEmergency Service HospitalRadionuclide ImagingBlood Flow VelocityDiabetic AngiopathiesMicrovascular Angina
researchProduct

Peptide receptor radionuclide therapy combined with chemotherapy

2019

ChemotherapyPeptide receptorbusiness.industrymedicine.medical_treatmentRadionuclide therapyCancer researchMedicinebusiness57. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin
researchProduct

Gallium-68 and scandium-44 labelled radiotracers based on curcumin structure linked to bifunctional chelators: Synthesis and characterization of pote…

2019

Abstract Curcumin metal complexes showed widespread applications in medicine and can be exploited as a lead structure for developing new tracers for nuclear medicine application. Herein, the synthesis, chemical characterization and radiolabelling with gallium-68 and scandium-44 of two new targeting vectors based on curcumin scaffolds and linked to the chelators 1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid (NODAGA) and 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)]amino-6-methylperhydro-1,4-diazepine (AAZTA) are reported. Synthesis of the precursors could be achieved with a 13% and 11% yield and radiolabelling generally afforded rapid incorporation under mild conditions (>95%). Sta…

CurcuminRadionuclide imagingGallium RadioisotopesPyrazole010402 general chemistry01 natural sciencesBiochemistryInorganic Chemistrychemistry.chemical_compoundMoietyAnimalsHumansTissue DistributionRadioactive TracersBifunctionalDerivatizationPET radiopharmaceuticalsChelating AgentsRadioisotopes010405 organic chemistryGallium-68Combinatorial chemistryIn vitro0104 chemical scienceschemistryYield (chemistry)Positron-Emission TomographyLipophilicityNuclear medicineCurcuminCurcumin; Gallium-68; Nuclear medicine; PET radiopharmaceuticals; Radionuclide imaging; Scandium-44RadiopharmaceuticalsScandium-44Scandium
researchProduct

In vivo comparison of DOTA based 68Ga-labelled bisphosphonates for bone imaging in non-tumour models.

2013

Bone metastases are a class of cancerous metastases that result from the invasion of a tumor into bone. The solid mass which forms inside the bone is often associated with a constant dull ache and severe spikes in pain, which greatly reduce the quality of life of the patient. Numerous (99m)Tc-labeled bisphosphonate functionalised complexes are well established tracers for bone metastases imaging. The objective of this research was to evaluate the pharmacokinetics and behaviour of three DOTA based bisphosphonate functionalised ligands (BPAMD, BPAPD and BPPED), using both (68)Ga μ-PET in vivo imaging and ex vivo biodistribution studies in healthy Wistar rats. The compounds were labelled with …

Diagnostic ImagingMaleCancer ResearchBiodistributionmedicine.medical_treatmentGallium RadioisotopesBone and Boneschemistry.chemical_compoundHeterocyclic Compounds 1-RingPharmacokineticsIn vivomedicineDOTAAnimalsRadiology Nuclear Medicine and imagingRats WistarRadionuclide ImagingDiphosphonatesChemistrybusiness.industrySoft tissueBisphosphonateRatsRadiographyIsotope LabelingMolecular MedicineNuclear medicinebusinessPreclinical imagingEx vivoNuclear medicine and biology
researchProduct

Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN,…

2020

Abstract Introduction This document is a summary of the French Intergroup guidelines regarding the management of digestive neuroendocrine neoplasms (NEN) published in February 2020 ( www.tncd.org ). Methods All French medical societies involved in the management of NEN took part in this work. Recommendations were graded into four categories (A, B, C or D), according to the level of evidence found in the literature until May 2019. Results The management of NEN is challenging because of their heterogeneity and the increasing complexity of diagnostic and therapeutic procedures. Pathological analysis is required for their diagnostic and prognostic characterization, which mainly relies on differ…

Diagnostic Imagingmedicine.medical_specialtyDiseaseDigestive System Neoplasms03 medical and health sciences0302 clinical medicineQuality of lifemedicineCarcinomaHumansEndoscopy Digestive SystemStage (cooking)Intensive care medicinePathologicalSocieties MedicalNeoplasm StagingHepatologybusiness.industryGastroenterologyEvidence-based medicinePrognosismedicine.diseaseCombined Modality TherapyClinical PracticeNeuroendocrine Tumors030220 oncology & carcinogenesisRadionuclide therapyQuality of LifeChromogranin A030211 gastroenterology & hepatologyFrancebusinessDigestive and Liver Disease
researchProduct

1st World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy (PRRNT), June 23-26, 2011, Zentralklinik Bad Berka, Germany

2011

EditorialPeptide receptorbusiness.industryRadionuclide therapyMedicinePhysiologybusinessBioinformaticsWorld Journal of Nuclear Medicine
researchProduct

90Y radioembolization in the treatment of neuroendocrine neoplasms: Results of an international multicenter retrospective study.

2021

In neuroendocrine neoplasms (NEN), the presence of distant metastases has a severe impact on survival leading to a relevant decrease of the 5-year survival rate. Here, 90Y radioembolization (RE) might be an important treatment option, however, data to support clinical benefits for RE are scarce. Therefore, the purpose of this study was to analyze the use of RE in NEN patients with hepatic metastases in an international, multi-center retrospective analysis and assess the potential role of RE in a multimodal treatment concept. Methods: 297 angiographic evaluations in NEN patients prior to RE were analyzed. Baseline characteristics and parameters derived from imaging evaluation and RE were ana…

Entire populationmedicine.medical_specialtyPeptide receptorbusiness.industryRetrospective cohort studyHepatologyGastroenterologyLog-rank testStatistical significanceInternal medicineRadionuclide therapymedicineRadiology Nuclear Medicine and imagingbusinessSurvival rateJournal of Nuclear Medicine
researchProduct

Total synthesis and evaluation of [18F]MHMZ.

2007

Radiochemical labeling of MDL 105725 using the secondary labeling precursor 2-[(18)F]fluoroethyltosylate ([(18)F]FETos) was carried out in yields of approximately 90% synthesizing [(18)F]MHMZ in a specific activity of approximately 50MBq/nmol with a starting activity of approximately 3GBq. Overall radiochemical yield including [(18)F]FETos synthon synthesis, [(18)F]fluoroalkylation and preparing the injectable [(18)F]MHMZ solution was 42% within a synthesis time of approximately 100 min. The novel compound showed excellent specific binding to the 5-HT(2A) receptor (K(i)=9.0 nM) in vitro and promising in vivo characteristics.

Fluorine RadioisotopesStereochemistryClinical BiochemistryPharmaceutical ScienceBiochemistryBinding CompetitiveRadioligand AssayPiperidinesIn vivoDrug DiscoveryAnimalsRadionuclide imagingReceptor Serotonin 5-HT2ARadionuclide ImagingMolecular BiologyChemistryOrganic ChemistrySynthonTotal synthesisBrainBiological activityRadioligand AssayRatsFluorobenzenesKineticsYield (chemistry)Isotope LabelingSerotonin 5-HT2 Receptor AntagonistsMolecular MedicineSpecific activityKetanserinSerotonin AntagonistsRadiopharmaceuticalsNuclear chemistryBioorganicmedicinal chemistry letters
researchProduct

Emission tomography with a large-hole collimator (CACAO): a possible new way to improve radionuclide imaging.

2002

This work aims to improve the quality of scintigraphy. It evaluates the use of a large-hole collimator, the Computer Aided Collimation Gamma Camera Project (CACAO), in SPECT. Acquisition data from the same object were simulated for CACAO and for a conventional collimator. Better signal-to-noise ratios were found for CACAO images, whatever the number of emitted photons. This work demonstrates that high-resolution images may be obtained with large-hole collimators. The combination of CACAO and pixilated detectors may further improve radionuclide imaging.

Image qualityImage processingIterative reconstructionCollimated light030218 nuclear medicine & medical imaginglaw.invention03 medical and health sciences0302 clinical medicineOpticslawImage Processing Computer-AssistedMedicineHumansRadiology Nuclear Medicine and imaging[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Radionuclide ImagingComputingMilieux_MISCELLANEOUSGamma camera[SDV.IB] Life Sciences [q-bio]/BioengineeringPhotonsbusiness.industryDetectorCollimator030220 oncology & carcinogenesisCalibration[SDV.IB]Life Sciences [q-bio]/Bioengineering[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]TomographybusinessNuclear medicineAlgorithmsJournal of computer assisted tomography
researchProduct